AllStar Health Brands Inc., (ALST) Announces Entering into Discussions for Acquisition of Revenue-Producing Supplement Company with Unique Products in Diabetes and Weight Management Space: Important in the Battle Against Covid-19

Rhea-AI Summary

AllStar Health Brands Inc. (OTC PINK:ALST) announced it is in discussions to acquire a revenue-generating company based in the Northeast US, specializing in health supplements targeting diabetes and weight management. These conditions are linked to heightened risks of Covid-19, making the acquisition strategically significant for AllStar's growth. The company aims to expand the distribution of these products across the US and potentially in other Americas. Additionally, AllStar is actively marketing Covid-19 rapid antibody tests and QuikLAB testing modules.

Positive

• Potential market expansion via acquisition of a revenue-producing company.
• Focus on health supplements related to diabetes and weight management, relevant to Covid-19.

Negative

• None.

MIAMI, FL / ACCESSWIRE / September 14, 2020 / AllStar Health Brands Inc. (OTC PINK:ALST) a specialty pharmaceutical and nutritional supplements company Provides Updates on its Operations

"We are in discussions to acquire a revenue-producing company based in the North East US with currently only a local reach. They have a small sales force promoting to Doctors' offices, unique Health Supplements in the Diabetes and Weight Management area. These two conditions are now known to increase both the morbidity and mortality of persons infected with the Covid-19 virus. AllStar believes these unique supplements may be beneficial in the overall strategy to combat the effects of Covid-19. This acquisition is also strategic for AllStar's growth and our goal is to expand the sales of these products throughout the US and possibly other countries in the Americas," stated Dr. Daniel Bagi, President of AllStar.

In other developments AllStar is continuing its efforts in the Marketing and Sales of Covid-19 rapid antibody tests and the sales of the QuikLAB testing modules announced previously.

About AllStar Health Brands Inc.:

AllStar Health Brands Inc. is a Nevada Corporation established in 2017, and headquartered in Miami, Florida. AllStar is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select products, including medical devices, nutritional supplements, over the counter remedies and medicines all across the Americas and Europe. AllStar's goal is to bring additional products to the market and provide new, innovative options for better health and wellbeing.

For more information, please contact Investor Relations at (305) 423 7028.

Safe Harbor Statement

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.

SOURCE: Allstar Health Brands, Inc.

View source version on accesswire.com:
https://www.accesswire.com/606028/AllStar-Health-Brands-Inc-ALST-Announces-Entering-into-Discussions-for-Acquisition-of-Revenue-Producing-Supplement-Company-with-Unique-Products-in-Diabetes-and-Weight-Management-Space-Important-in-the-Battle-Against-Covid-19

FAQ

What acquisition is AllStar Health Brands Inc. pursuing?

AllStar Health Brands is discussing an acquisition of a revenue-producing company specializing in diabetes and weight management health supplements.

Why is the acquisition important for AllStar Health Brands Inc.?

The acquisition is strategic for growth, aiming to expand sales of relevant health products, particularly in the context of Covid-19.

What products is AllStar focusing on alongside the acquisition?

AllStar is also focusing on marketing Covid-19 rapid antibody tests and QuikLAB testing modules.

What are the expected benefits of the acquisition for ALST investors?

Investors may benefit from expanded market reach and potential revenue growth from newly acquired products.